- Home
- ETON vs PETS Comparison
ETON vs PETS Comparison
Compare ETON & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- PETS
- Stock Information
- Founded
- ETON 2017
- PETS 1996
- Country
- ETON United States
- PETS United States
- Employees
- ETON N/A
- PETS N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- PETS Retail-Drug Stores and Proprietary Stores
- Sector
- ETON Health Care
- PETS Consumer Staples
- Exchange
- ETON Nasdaq
- PETS Nasdaq
- Market Cap
- ETON 199.5M
- PETS 82.0M
- IPO Year
- ETON 2018
- PETS N/A
- Fundamental
- Price
- ETON $8.82
- PETS $4.07
- Analyst Decision
- ETON Strong Buy
- PETS Sell
- Analyst Count
- ETON 3
- PETS 2
- Target Price
- ETON $12.00
- PETS $3.50
- AVG Volume (30 Days)
- ETON 214.1K
- PETS 182.6K
- Earning Date
- ETON 11-11-2024
- PETS 11-06-2024
- Dividend Yield
- ETON N/A
- PETS 29.41%
- EPS Growth
- ETON N/A
- PETS N/A
- EPS
- ETON N/A
- PETS N/A
- Revenue
- ETON $31,381,000.00
- PETS $270,772,000.00
- Revenue This Year
- ETON $19.61
- PETS N/A
- Revenue Next Year
- ETON $35.39
- PETS $3.27
- P/E Ratio
- ETON N/A
- PETS N/A
- Revenue Growth
- ETON 8.14
- PETS 2.26
- 52 Week Low
- ETON $3.03
- PETS $2.90
- 52 Week High
- ETON $8.66
- PETS $8.27
- Technical
- Relative Strength Index (RSI)
- ETON 76.07
- PETS 56.76
- Support Level
- ETON $7.58
- PETS $3.78
- Resistance Level
- ETON $8.66
- PETS $4.17
- Average True Range (ATR)
- ETON 0.42
- PETS 0.18
- MACD
- ETON -0.07
- PETS -0.01
- Stochastic Oscillator
- ETON 91.49
- PETS 62.22
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About PETS PetMed Express Inc.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.